- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon gamma in cancer immunotherapy
Authors
Keywords
-
Journal
Cancer Medicine
Volume 7, Issue 9, Pages 4509-4516
Publisher
Wiley
Online
2018-07-24
DOI
10.1002/cam4.1700
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon-gamma induces autophagy-associated apoptosis through induction of cPLA2-dependent mitochondrial ROS generation in colorectal cancer cells
- (2018) Qiu-Shuang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab
- (2018) Brandon W. Higgs et al. CLINICAL CANCER RESEARCH
- IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling
- (2018) Yi Gao et al. INTERNATIONAL JOURNAL OF CANCER
- IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
- (2018) Hussein F. Aqbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment
- (2018) P. Xiao et al. ONCOGENE
- Interferon-γ and Colorectal Cancer: an up-to date
- (2018) Christoforos Kosmidis et al. Journal of Cancer
- Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner
- (2018) Moritz F. Eissmann et al. Cancer Immunology Research
- Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies
- (2017) Johann Pötzl et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade
- (2017) Thomas B. Huffaker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
- (2017) Yuying Liu et al. Nature Communications
- Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
- (2017) Hiroaki Shime et al. OncoImmunology
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
- (2016) Josephine F. Trott et al. Oncotarget
- Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB
- (2016) Micaela Morgado et al. Oncotarget
- Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
- (2015) Lu Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines
- (2015) NANNAN LV et al. Oncology Letters
- Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
- (2015) Roberto Bellucci et al. OncoImmunology
- RelA-Induced Interferon Response Negatively Regulates Proliferation
- (2015) Bose S. Kochupurakkal et al. PLoS One
- IFN-γ regulates survival and function of tumor-induced CD11b+Gr-1highmyeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1
- (2014) José Medina-Echeverz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
- (2014) Soo Kyung Jeong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- IFN-γ Mediates the Antitumor Effects of Radiation Therapy in a Murine Colon Tumor
- (2013) Scott A. Gerber et al. AMERICAN JOURNAL OF PATHOLOGY
- Interferon-γ produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells
- (2013) Yi Lu et al. ANGIOGENESIS
- M2-polarised macrophages in infantile haemangiomas: correlation with promoted angiogenesis
- (2013) Feng-Qin Wang et al. JOURNAL OF CLINICAL PATHOLOGY
- Downregulation of IFNG in CD4+ T Cells in Lung Cancer through Hypermethylation: A Possible Mechanism of Tumor-Induced Immunosuppression
- (2013) Fang Wang et al. PLoS One
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN- Inducible Chemokines
- (2012) W. Peng et al. CANCER RESEARCH
- Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
- (2012) Martina J Schmitt et al. Cell Communication and Signaling
- Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN- and GM-CSF
- (2012) P. Spear et al. JOURNAL OF IMMUNOLOGY
- Twist1 Regulates Ifng Expression in Th1 Cells by Interfering with Runx3 Function
- (2012) D. Pham et al. JOURNAL OF IMMUNOLOGY
- PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
- (2012) John Dulos et al. JOURNAL OF IMMUNOTHERAPY
- Cellular teamwork in antibacterial innate immunity
- (2012) Janelle S Ayres et al. NATURE IMMUNOLOGY
- Comparison of the Regulation of β-Catenin Signaling by Type I, Type II and Type III Interferons in Hepatocellular Carcinoma Cells
- (2012) Wei Li et al. PLoS One
- Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity
- (2012) Thomas B. Huffaker et al. Cell Reports
- The origins of cancer robustness and evolvability
- (2010) Tianhai Tian et al. Integrative Biology
- Anti-CTLA-4 therapy results in higher CD4+ICOShiT cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
- (2009) Hong Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More